Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis

Ana I. TergasDepartment of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY, USA;Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA;Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USACorrespondence[email protected]

Alfred I. NeugutDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA;Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA;Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA

Ling ChenDepartment of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY, USA

William M. BurkeDepartment of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY, USA

Dawn L. HershmanDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA;Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA;Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY, USA

Jason D. WrightDepartment of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York, NY, USA;Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA;Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA

ABSTRACT

This study examines factors associated with prolonged radiation duration and its impact on survival in women with cervical cancer treated with primary chemoradiation. Women in the National Cancer Database with stage IB2-IVA cervical cancer from 2003 to 2011 who received radiation and chemotherapy were included. Of 7209 women, who met inclusion criteria, 3401 (47.1%) and 3808 (52.8%) completed radiation in ≤ 8 and > 8 weeks, respectively. There was no overall survival difference for radiation duration ≤ 8 vs. > 8 weeks. Sensitivity analyses showed that inferior overall survival is only seen with radiation duration of > 10–12 weeks.

Keywords:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis

Information for

Open access

Opportunities

Help and information

Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis

ABSTRACT

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature